#97Regional leaders 1–100

Xellia Pharmaceuticals

Denmark · European Union

Sterile and injectable productsAntibiotics and fermentationFinished dosage forms and small molecules

Manufacturing profile

Country
Denmark
Regulatory region
European Union
ISO
DNK

Selection basis

The company is placed in positions 1–100 as a major regional manufacturer, biopharmaceutical group, important generics supplier or manufacturing/CDMO leader.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1WFI, clean steam and cleanroom HVAC
  2. 2Solution preparation and bioburden control
  3. 3Sterile filtration
  4. 4Isolator/RABS filling or lyophilisation
  5. 5Sterility, endotoxin, particles and container-closure QC
  6. 6Seed preparation and industrial fermentation
  7. 7Broth clarification and primary recovery
  8. 8Extraction, crystallisation and purification
  9. 9Sterile or non-sterile formulation

Relevant FUZKK packages

Lumex — instrumental QC

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology